Clinical trial methodology in rare gynecologic tumor research: Strategies for success.

A Comprehensive Program Enabling Effective Delivery of Regional Genetic Counseling.

Phase 2 study evaluating intermittent and continuous linsitinib and weekly paclitaxel in patients with recurrent platinum resistant ovarian epithelial cancer.

Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?

Proceedings From the 1st International Conference 'Current Concepts and Controversies in Gynecologic and Urologic Oncology'.

Salvage chemotherapy for gestational trophoblastic neoplasia: Utility or futility?

Physician Education on Controllable Costs Significantly Reduces Cost of Laparoscopic Hysterectomy.

15years of progress in gestational trophoblastic disease: Scoring, standardization, and salvage.

Randomized Phase II Trial of Seribantumab in Combination With Paclitaxel in Patients With Advanced Platinum-Resistant or -Refractory Ovarian Cancer.

Adverse Event Profile by Folate Receptor Status for Vintafolide and Pegylated Liposomal Doxorubicin in Combination, Versus Pegylated Liposomal Doxorubicin Alone, in Platinum-Resistant Ovarian Cancer: Exploratory Analysis of the Phase II PRECEDENT Trial.